Epistemic responsibilities in the COVID-19 pandemic: Is a digital infosphere a friend or a foe

被引:7
|
作者
Curkovic, Marko [1 ,2 ]
Kosec, Andro [2 ,3 ]
Bedekovic, Marina Roje [4 ]
Bedekovic, Vladimir [2 ,3 ]
机构
[1] Univ Psychiat Hosp Vrapce, Bolnicka Cesta 32, Zagreb 10090, Croatia
[2] Univ Zagreb, Sch Med, Salata 2, Zagreb 10000, Croatia
[3] Univ Hosp Ctr Sestre Milosrdnice, Dept Otorhinolaryngol & Head & Neck Surg, Vinogradska Cesta 29, Zagreb 10000, Croatia
[4] Univ Hosp Ctr Sestre Milosrdnice, Dept Neurol, Vinogradska Cesta 29, Zagreb 10000, Croatia
关键词
Information; CoViD-19; Epistemology; Data science; Digital intermediary;
D O I
10.1016/j.jbi.2021.103709
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Digital technologies have a significant role in collecting, filtering and disseminating information, allowing for social, healthcare and economic activities even in the context of highly restrictive public health measures in the current COVID-19 pandemic. As personal contact is greatly reduced, they also create a shared informational landscape, allowing for a shared threat response. This is a difficult task, since truthfulness of content that leads to actionable knowledge is impossible to consistently validate. So, not only that curation of information is rarely congruent with pressing health issues, but digital spaces may also become fertile ground for misinformation and disinformation, contributing to the devastating effects of an infodemic. Digital intermediaries are useful exactly because their representation of reality is not a true construct, but a result of purposely curated information. However, they are active, dynamic epistemological agents with their own logic and aim. In dealing with a pandemic, we should reconsider the ways how our digital informational landscapes are created and sustained. This urges us to consider ethical governance of digital data curation and dissemination, alongside forms of control of the truthfulness and reach of its content. Some of the most fundamental issues in dealing with the COVID-19 pandemic, including the newly available vaccines are reliant on digital information and data sharing among experts, and the role of informing the general public. The need to create a reproducible, valid and truthful informational landscape is paramount, while allowing for free and rational, behavioral individual choices oriented toward preserving and promoting healthy behavior. These are issues at the heart of dealing with any pandemic, as well as a well-organized health care policy.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Toll-like receptor 4 in COVID-19: friend or foe?
    Mukherjee, Suprabhat
    [J]. FUTURE VIROLOGY, 2022, 17 (07) : 415 - 417
  • [32] BIOLOGIC AGENTS FOR RHEUMATIC DISEASES IN THE COVID-19 OUTBREAK: FRIEND OR FOE?
    Santos, Cristiana S.
    Moriano Morales, Claim
    Diez Alvarez, Elvira
    Alvarez Castro, Caroling
    Lopez Robles, Alejandra
    Perez Sandoval, Trinidad
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S3 - S4
  • [33] Glucocorticoids in COVID19; a friend not foe
    Owlia, Sina
    Owlia, Mohammad Bagher
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [34] Friend or Foe - The Potential Mechanisms of Nicotine's Protective Role in COVID-19
    Lin, Mosi
    Zefi, Sidorela
    Zhao, Warren
    Ashby, Charles
    Mantell, Lin
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S89 - S89
  • [35] Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?
    Lewandowski, Konrad
    Kaniewska, Magdalena
    Rosolowski, Mariusz
    Tworek, Adam
    Rydzewska, Grazyna
    [J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2022, 17 (03): : 219 - 226
  • [36] Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
    Mehta, Puja
    Chambers, Rachel C.
    Dagna, Lorenzo
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (06): : E394 - E395
  • [37] From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors
    Kidde, Jason
    Sahebkar, Amirhossein
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 174 - 175
  • [38] Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    Badagliacca, Roberto
    Sciomer, Susanna
    Petrosillo, Nicola
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (07): : 729 - 730
  • [39] SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?
    Scheen, A. J.
    [J]. DIABETES & METABOLISM, 2020, 46 (05) : 343 - 344
  • [40] People' responsibilities and adaptation in the struggle against the COVID-19 pandemic
    Demirkiran, Mustafa
    Yorulmaz, Mehmet
    Uysal, Burhanettin
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 (04): : 452 - 456